Logo image of ETX

EATON VANCE MUNI INC 2028 TM (ETX) Stock Price, Quote, News and Overview

NYSE:ETX - New York Stock Exchange, Inc. - US27829U1051 - Currency: USD

18.01  0 (0%)

Fundamental Rating

2

Overall ETX gets a fundamental rating of 2 out of 10. We evaluated ETX against 0 industry peers in the Unkown industry. Both the profitability and financial health of ETX have multiple concerns. ETX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ETX was profitable.
The reported net income has been mixed in the past 5 years: ETX reported negative net income in multiple years.
ETX had a positive operating cash flow in 4 of the past 5 years.
ETX Yearly Net Income VS EBIT VS OCF VS FCFETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA 2.78%
ROE 3.22%
ROIC 2.49%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETX Yearly ROA, ROE, ROICETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

ETX's Profit Margin has declined in the last couple of years.
ETX's Operating Margin has improved in the last couple of years.
ETX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 76.07%
PM (TTM) 67.89%
GM 78.32%
OM growth 3Y0.61%
OM growth 5Y4.19%
PM growth 3YN/A
PM growth 5Y-18.26%
GM growth 3Y0.99%
GM growth 5Y4.45%
ETX Yearly Profit, Operating, Gross MarginsETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 150

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for ETX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ETX Yearly Shares OutstandingETX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ETX Yearly Total Debt VS Total AssetsETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.72 indicates that ETX is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.15 indicates that ETX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 3.72
ROIC/WACCN/A
WACCN/A
ETX Yearly LT Debt VS Equity VS FCFETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.68 indicates that ETX should not have too much problems paying its short term obligations.
ETX has a Quick Ratio of 1.68. This is a normal value and indicates that ETX is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
ETX Yearly Current Assets VS Current LiabilitesETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

ETX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.79%, which is quite impressive.
ETX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.25% yearly.
Looking at the last year, ETX shows a very negative growth in Revenue. The Revenue has decreased by -13.85% in the last year.
ETX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.03% yearly.
EPS 1Y (TTM)29.79%
EPS 3YN/A
EPS 5Y-23.25%
EPS Q2Q%-36.96%
Revenue 1Y (TTM)-13.85%
Revenue growth 3Y-8.22%
Revenue growth 5Y-6.03%
Sales Q2Q%-10.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETX Yearly Revenue VS EstimatesETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.52, the valuation of ETX can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 26.65, ETX is valued at the same level.
Industry RankSector Rank
PE 29.52
Fwd PE N/A
ETX Price Earnings VS Forward Price EarningsETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ETX Per share dataETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

ETX has a Yearly Dividend Yield of 5.20%, which is a nice return.
ETX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 5.2%

5.2 History

The dividend of ETX decreases each year by -2.87%.
ETX has been paying a dividend for at least 10 years, so it has a reliable track record.
ETX has decreased its dividend recently.
Dividend Growth(5Y)-2.87%
Div Incr Years1
Div Non Decr Years1
ETX Yearly Dividends per shareETX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The Dividend Rate of ETX has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ETX Yearly Income VS Free CF VS DividendETX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

More info and screens

EATON VANCE MUNI INC 2028 TM

NYSE:ETX (6/24/2025, 11:46:19 AM)

18.01

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners21.14%
Inst Owner Change-4.56%
Ins Owners0.04%
Ins Owner Change0%
Market Cap196.13M
Analysts0
Price TargetN/A
Short Float %0.32%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield 5.2%
Yearly Dividend0.74
Dividend Growth(5Y)-2.87%
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-16 2025-06-16 (0.0782)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.52
Fwd PE N/A
P/S 20.05
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)0.61
EY3.39%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.9
BVpS18.92
TBVpS18.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 3.22%
ROCE 3.15%
ROIC 2.49%
ROICexc 2.54%
ROICexgc 2.54%
OM 76.07%
PM (TTM) 67.89%
GM 78.32%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.61%
OM growth 5Y4.19%
PM growth 3YN/A
PM growth 5Y-18.26%
GM growth 3Y0.99%
GM growth 5Y4.45%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 3.72
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.79%
EPS 3YN/A
EPS 5Y-23.25%
EPS Q2Q%-36.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.85%
Revenue growth 3Y-8.22%
Revenue growth 5Y-6.03%
Sales Q2Q%-10.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.74%
EBIT growth 3Y-7.66%
EBIT growth 5Y-2.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A